≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

KELA_REIMBURSEMENT_202

MESH PheWeb

K11_REIMB_202

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

KELA reimbursements: KELA codes 202

19458

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

19458

diagram downward connector

Check minimum number of events None

19458

diagram downward connector

Include endpoints None

19458

diagram downward connector
K11_REIMB_202

Extra metadata

First used in FinnGen datafreeze DF3

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 19458 12676 6782
Unadjusted prevalence (%) 5.47 6.39 4.31
Mean age at first event (years) 46.62 45.39 48.92

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.03 1.97 [1.71, 2.27] 7.0e-21 1963
15 years 0.01 1.43 [1.28, 1.61] 9.8e-10 912
5 years 0.00 2.00 [1.76, 2.27] 8.3e-27 388
1 year 0.00 2.43 [1.92, 3.07] 1.1e-13 87

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: K11_REIMB_202 – KELA_REIMBURSEMENT_202
GWS hits: 30

Survival analyses between endpoints

↥

Plot

before KELA_REIMBURSEMENT_202
after KELA_REIMBURSEMENT_202

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after KELA_REIMBURSEMENT_202

↥